Long-Acting Injectable Cabotegravir Highly Effective at Preventing HIV Infection
May 18, 2020
Myron Cohen, MD, the Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, co-led a global randomized, controlled and double-blinded study that shows the drug cabotegravir lowered HIV incidence among cisgender men and transgender women who have sex with men. An announcement about the study was published in the...